Nutrient quality
Meaningful amounts and a well-regarded chromium form create a focused metabolic formula. Unspecified omega-3 fractions and alpha-lipoic-acid form limit quality detail.
Daily Vita | $ 24.61 | |
| $ 24.61 | ||
Walmart | $ 21.55 | |
| $ 22.91 | ||
Amazon | $ 20.49 | |
Vitacost | $ 25.87 |
The formula pairs 200 mcg of chromium nicotinate glycinate with 300 mg of alpha-lipoic acid. Both are clearly quantified and align more strongly with glucose handling and metabolism than with direct fat loss.
Total omega-3 reaches 896 mg, but EPA, DHA, source, and molecular form are not disclosed. That omission makes its cardiovascular and skin-related contribution difficult to judge precisely.
The two-softgel serving is practical and the ingredients work together without unnecessary complexity. People using insulin or sulfonylureas need closer glucose monitoring because chromium and alpha-lipoic acid may add to their effects.
Meaningful amounts and a well-regarded chromium form create a focused metabolic formula. Unspecified omega-3 fractions and alpha-lipoic-acid form limit quality detail.
The three main active totals and implied serving size are visible. Missing fatty-acid detail, directions, and non-active ingredients reduce clarity.
The aggregate rating is favorable and backed by a substantial review volume. No specific comments are available to assess recurring problems or real-world fit.
Meaningful core doses provide fair formula value. Incomplete omega-3 detail limits comparison with stronger alternatives.
Chromium and alpha-lipoic acid provide targeted support for insulin sensitivity and glucose handling. Omega-3 adds cardiometabolic context, although its EPA and DHA amounts are not disclosed.
The chromium form and both glycemic actives are clearly quantified at practical amounts. Chromium and alpha-lipoic acid may lower blood glucose, so people using insulin or sulfonylureas should monitor for low blood sugar with clinical guidance.
Chromium and alpha-lipoic acid provide a coherent glucose-metabolism pairing, while omega-3 fats add broader metabolic support. All three actives are clearly measured at meaningful amounts.
Evidence for direct weight loss remains limited, and the formula has no satiety, protein, or thermogenic ingredient. Chromium and alpha-lipoic acid may lower blood glucose, so insulin or sulfonylurea users need monitoring for low blood sugar.
Omega-3 fats and alpha-lipoic acid offer barrier and antioxidant relevance, though the formula is built for glucose support. Alpha-lipoic acid has antioxidant evidence, but the full formula lacks direct human trials for skin outcomes.
The 896 mg total omega-3 amount is moderate, but active EPA and DHA amounts are not separated. Chromium and alpha-lipoic acid may add to glucose-lowering medicines and warrant closer glucose monitoring.
| Ingredient | Amount per serving |
|---|---|
Calories | 15 Calorie(s) |
Total Fat | 1.5 Gram(s) |
Chromium (Chromium Nicotinate Glycinate) | 200 mcg |
Alpha-Lipoic Acid | 300 mg |
Total Omega-3 Fatty Acids | 896 mg |
Chromium nicotinate glycinate offers a bioavailable 200 mcg dose supported by 300 mg of alpha-lipoic acid. The companion active improves the formula's value despite a higher chromium-specific cost. Chromium and alpha-lipoic acid may both lower blood glucose, so people using insulin or sulfonylureas should monitor for low blood sugar with clinical guidance.
The formula provides 896 mg of total omega-3 without disclosing separate EPA and DHA amounts. Missing form, source, antioxidant, and purity details limit confidence in quality and value. Chromium and alpha-lipoic acid may lower blood glucose, so people using glucose-lowering medicines may need closer monitoring.
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.